Specialty producer Verdesian Life Sciences, Cary, N.C., reports that it has entered into a definitive stock purchase agreement with funds managed by AEA Investors LP, New York City. Verdesian’s management team, including President and CEO Kenny Avery, will continue to lead the company following the close of the transaction. Paine Schwartz Partners, New York City, formed Verdesian in 2012.